Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by JonEcashon Feb 03, 2021 9:15pm
206 Views
Post# 32466780

RE:It's a good thing

RE:It's a good thing

I was also shocked when I first saw news of the financing. Further dilution was the furthest thing from what I expected given they were cashed up from the warrants, and would not have to spend in any collaborations. 

BUT, on further consideration I believe this to be good news overall:
1. We now understand the recent trading and Anon's actions.

2. We have set a fundamental floor IMO. We aren't going below $1.20. And if we do not far and not for long.

3. This was a bought deal, bringing in new institutional investment, support, and awareness.

4. Leede is a co-lead underwriter. Guess who's analyst put out the $2.50 target? They will help ensure that this is a reality.

5. Having a solid investment banking advisor is critical during significant negotiations and valuations. Maybe this was the price of getting Canaccord involved?

6. The Company has to have a strategic use for that extra $10M for right now. As others have alluded to, perhaps this is to accelerate their other indications, tech, or...?

7. We've had what, 3 bits of news from this Company in 3 days this week? Means so much must be happening, and quickly, behind the scenes. So am excited to hold and find out. 
 

My only frustration is having bought so much more at way higher than here. Had I been a bit more patient, or known, I could have loaded up at these levels. So this is a gift to anyone else still on the sidelines or wondering if they should buy more. 

J$
 

<< Previous
Bullboard Posts
Next >>